The risk of worsening of myasthenia by cardiovascular medication as reflected by reporting frequency.
Peter TrillenbergAlexander KatalinicJulia ThernTobias GrafPublished in: European journal of neurology (2021)
Angiotensin receptor antagonists, angiotensin-converting enzyme inhibitors, and diuretics seem to be safe in antihypertensive therapy. Surprisingly, and yet requiring confirmation by case reports, alpha receptor-blocking drugs seem to carry a risk of myasthenia worsening. Amiodarone seems to be a safe alternative in antiarrhythmic therapy in patients with myasthenia.